Various Antihypertensive Drug Compliance Models and Cardiovascular Prognosis of People With Incidentally Detected High Blood Pressure During Health Check-Up in Korea

韩国健康体检中偶然发现高血压患者的各种降压药物依从性模型及心血管预后

阅读:2

Abstract

BACKGROUND: A health check-up system (HCS) is one of the best ways to prevent complications and maintain health by diagnosing diseases and screening risk factors early. Here, we investigated how many people who detected elevated blood pressure through the HCS were finally diagnosed with "hypertension" and continuously treated. We also analyzed their cardiovascular risk and prognostic significance according to the multiple drug compliance patterns. METHODS: A total of 38,100 subjects without cardiovascular disease who were newly detected with elevated blood pressure in HCS between 2006 and 2011 were analyzed and followed up until 2019 using the Korean National Health Insurance Database. They were divided into five subgroups through subsequent prescription history and compared for epidemiological, laboratory performance and cardiovascular events. RESULTS: Of the total 38,100 subjects, 6981 (18.3%) cases were diagnosed with hypertension and started medication within 12 months. Of those cases, 3021 (7.9%) cases continued taking their medication, 2184 (5.7%) cases persistently discontinued medication, and 485 (1.3%) cases restarted medication again within 12 months of discontinuation. As a result of follow-up until 2019, the "drug-free group" showed the significantly lowest cardiovascular complication incidences (angina, heart failure, ischemic heart disease, CKD, and PAOD), and the highest were seen in the "re-initiation group" (cerebral infarct and atrial fibrillation) compared with the "continuous medication group." CONCLUSIONS: A considerable proportion of individuals with high blood pressure detected in HCS were diagnosed with hypertension and at high cardiovascular risk. The group that needed to restart medication within 12 months after discontinuation showed a higher cardiovascular risk among them.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。